Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05484622 |
|---|---|
| Brief Title: | Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive Enhancing IDH-1 Mutant Glioma |
| First Submitted : | July 21, 2022 |
| First Submitted that Met QC Criteria : | August 1, 2022 |
| First Posted : | August 2, 2022 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 8, 2024 |